Table 2.
Linear regression analysis of variables associated with IgG antibody titre after BNT162b2.
| B | SE | Beta | P value | |
|---|---|---|---|---|
| Age | − 0.021 | 0.001 | − 0.399 | < 0.001 |
| Sex (base: male) | 0.082 | 0.035 | 0.040 | 0.019 |
| Date from 2nd vaccination | − 0.014 | 0.001 | − 0.431 | < 0.001 |
| Interval between vaccinations (base: 21 day) | ||||
| < 21 days | 0.017 | 0.082 | 0.003 | 0.834 |
| 22–28 days | 0.130 | 0.042 | 0.051 | 0.002 |
| > 28 days | 0.080 | 0.058 | 0.022 | 0.167 |
| Smoking (base: none) | − 0.181 | 0.042 | − 0.070 | < 0.001 |
| Alcohol (base: none) | ||||
| Sometimes | − 0.040 | 0.038 | − 0.017 | 0.300 |
| Everyday | − 0.022 | 0.046 | − 0.008 | 0.627 |
| Daily medication (base: none) | ||||
| Steroids | − 0.772 | 0.117 | − 0.111 | < 0.001 |
| Immunosuppression | − 0.636 | 0.178 | − 0.060 | < 0.001 |
| NSAIDs | − 0.045 | 0.061 | − 0.012 | 0.459 |
| Acetaminophen | 0.001 | 0.108 | 0.000 | 0.990 |
| Antihistamines | − 0.107 | 0.068 | − 0.025 | 0.115 |
| Comorbidities (base: none) | ||||
| Hypertension | 0.106 | 0.043 | 0.047 | 0.013 |
| Diabetes | − 0.191 | 0.063 | − 0.049 | 0.003 |
| Heart disease | − 0.132 | 0.061 | − 0.035 | 0.031 |
| Kidney disease | − 0.209 | 0.150 | − 0.022 | 0.162 |
| Cancer | 0.012 | 0.086 | 0.002 | 0.887 |
| Connective tissue disease | − 0.285 | 0.123 | − 0.040 | 0.021 |
| Immune deficiency | 0.051 | 0.307 | 0.003 | 0.869 |
| Adverse reaction (base: none) | ||||
| 1 | 0.271 | 0.044 | 0.112 | < 0.001 |
| 2≥ | 0.311 | 0.042 | 0.155 | < 0.001 |
Connective tissue disease included Rheumatism.
Adverse reaction included whole body adverse reaction at 2nd dose (> 37.5 °C fever, fatigue, headache, joint pain, diarrhea, nausea, dizziness, and other).
NSAIDs, non-steroidal anti-inflammatory drugs.